Look-alike, sound-alike (LASA) drugs in India.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 38798984.
- Also identified by DOI 10.1016/j.lansea.2024.100425 and PMC identifier 11127203.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Poor drug regulation in India is not a recent problem. The Indian drug market is full of look-alike, sound-alike (LASA) drugs which have not yet caught the attention of the media or the medical community. This viewpoint highlights the problem of LASA drugs and poor prescription practices and proposes solutions for involving all stakeholders in this unaddressed issue which is a huge public health problem in India.